NUCLEOPHOSMIN DIRECTED DIAGNOSTICS AND THERAPEUTICS FOR MULTIDRUG RESISTANT NEOPLASTIC DISEASE

Details for Australian Patent Application No. 2003302986 (hide)

Owner AURELIUM BIOPHARMA INC.

Inventors SERFASS, Lucile; BONNEAU, AnneMarie; DALLAIRE, Frederic; GEORGES, Elias

Pub. Number AU-A-2003302986

PCT Number PCT/IB2003/0064

PCT Pub. Number WO2004/055517

Priority 60/433,351 13.12.02 US

Filing date 15 December 2003

Wipo publication date 9 July 2004

International Classifications

G01N 033/574 Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

5 August 2004 Complete Application Filed

  Priority application(s): 60/433,351 13.12.02 US

19 August 2004 Application Open to Public Inspection

  Published as AU-A-2003302986

22 September 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003302987-COLLAPSE TOLERANT FLEXIBLE PIPE AND METHOD OF MANUFACTURING SAME

2003302985-HARDWARE SECURITY DEVICE FOR MAGNETIC MEMORY CELLS